The future of interventional cardiology lies in the left atrium

International Journal of Cardiovascular Interventions

Volumn 6, Issue 3-4, 2004, Pages 101-106

  Solomon, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Catheters; Devices; Left atrium; Mitral regurgitation; Patent foramen ovale

Indexed keywords

BALLOON CATHETER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY STENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART ATRIUM THROMBOSIS; HEMODYNAMIC MONITORING; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PULMONARY VEIN; REVIEW;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; HEART ATRIA; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MITRAL VALVE INSUFFICIENCY; THROMBOSIS;

EID: 10844282021     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840410030432     Document Type: Review

References (46)

1. Kozak LJ, Hall MJ, Owings MF. National Hospital Discharge Survey: 2000 Annual Summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat, no. 153. DHHS Publication No. (PHS) 2003-1724.
2. Rihal CS, Raco DL, Cersh BJ, Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 2003; 108: 2439-45.
3. Cope C. Technique for trans-septal catheterization of the left atrium; preliminary report. J Thorac Surg 1959; 37: 482-6.
4. Ross J Jr, Braunwald E, Morrow AG. Trans-septal left atrial puncture; new technique for the measurement of left atrial pressure in man. Am J Cardiol 1959; 3: 653-5.
5. Singh JP, Evans JC, Levy D et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83: 897-902.
6. Ling H, Enriquez-Sarano M, Seward J et al. Clinical outcome of mitral regurgitation due to flail leaflets. N Engl J Med 1996; 335: 1417-23.
7. Society of Thoracic Surgery Database 2003. www.sts.org.
8. Otto CM. Timing of surgery in mitral regurgitation. Heart. 2003; 89: 100-5.
9. DeAnda A Jr, Kasirajan V, Higgins RS. Mitral valve replacement versus repair in 2003: where do we stand? Curr Opin Cardiol 2003; 18: 102-5.
10. Block PC. Percutaneous mitral valve repair for mitral regurgitation. J Interv Cardiol 2003; 16: 93-6.
11. Condado JA, Velez-Gimon M. Catheter-based approach to mitral regurgitation. J Interv Cardiol 2003; 16: 523-34.
12. Maisano F, Caldarola A, Blasio A, De Bonis M, La Canna G, Alfieri O. Midterm results of edge-to-edge mitral valve repair without annuloplasty. J Thorac Cardiovasc Surg 2003; 126: 1987-97.
13. St Goar FG, Fann JI, Komtebedde J et al. Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation 2003; 108: 1990-3 Epub 2003 Oct 06.
14. Alfieri O, Elefteriades JA, Chapolini RJ et al. Novel suture device for beating-heart mitral leaflet approximation. Ann Thorac Surg 2002; 74: 1488-93.
15. Kaye DM, Byrne M, Alferness C, Power J. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 2003; 108: 1795-7 Epub 2003 Oct 06.
16. Liddicoat JR, MacNeill BD, Gillinov AM et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv 2003; 60: 410-6.
17. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
18. Connolly SJ. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts. Am Heart J 2003; 145: 418-23.
19. Hart RG, Halperin JL, Pearce LA et al. Stroke prevention in atrial fibrillation investigators. Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 2003; 138: 831-8.
20. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119(1 Suppl): 108S-121S.
21. Stafford R, Singer DE. National patterns of warfarin use in atrial fibrillation. Arch Intern Med 1996; 156: 2537-41.
22. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61: 755-9.
23. Crystal E, Lamy A, Connolly SJ et al. Left Atrial Appendage Occlusion Study. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. Am Heart J 2003; 145: 174-8.
24. Ostermayer S, Reschke M, Billinger K et al. Percutaneous closure of the left atrial appendage. J Interv Cardiol 2003; 16: 553-6.
25. Sievert H, Lesh MD, Trepels T et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002; 105: 1887-9.
26. Meier B, Palacios I, Windecker S et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60: 417-22.
27. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59: 17-20.
28. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001; 38: 613-23.
29. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13: 102-6.
30. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003; 139: 753-60.
31. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003; 16: 39-42.
32. Bridges ND, Hellenbrand W, Latson L et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992; 86: 1902-8.
33. Park JC, Pediatric Cardiology for Practitioners, 4th ed., 2002: 129-30.
34. Baskett RJ, Tancock E, Ross DB. The gold standard for atrial septal defect closure: current surgical results, with an emphasis on morbidity. Pediatr Cardiol 2003; 24: 444-7.
35. Martin F, Sanchez PL, Doherty E et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002; 106: 1121-6.
36. Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM. Amplatzer PFO Investigators. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the US multicenter clinical trial. Catheter Cardiovasc Interv 2003; 60: 524-8.
37. Onorato E, Melzi G, Casilli F et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003; 16: 43-50.
38. Tsang TS, Petty GW, Barnes ME et al. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol 2003; 42: 93-100.
39. Prasad SM, Maniar HS, Camillo CJ et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg 2003; 126: 1822-8.
40. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-66.
41. Weinstock J, Wang PJ, Homoud MK, Link MS, Estes NA 3rd. Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia. J Interv Card Electrophysiol 2003; 9: 275-88.
42. Natale A, Pisano E, Shewchik J et al. First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 2000; 102: 1879-82.
43. Meininger GR, Calkins H, Lickfett L et al. Initial experience with a novel focused ultrasound ablation system for ring ablation outside the pulmonary vein. J Interv Card Electrophysiol 2003; 8: 141-8.
44. Masoudi FA, Havranek EP, Krumholz HM. The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev 2002; 7: 9-16.
45. Magalski A, Adamson P, Gadler F et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail 2002; 8: 63-70.
46. Braunschweig F, Linde C, Eriksson MJ, Hofman-Bang C, Ryden L. Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 2002; 23: 59-69.